Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Experts call for national pregnancy screening policy

This article was originally published in Clinica

Executive Summary

The UK urgently needs a national policy on pregnancy screening to overcome regional inequities, say researchers from the Wolfson Institute of Preventive Medicine at St Bartholomew's Hospital in London. The proportion of health regions and boards using age alone to determine screening for Down's syndrome and other congenital abnormalities fell from 49% in 1991 to 23% in 1994, says Dr Nicholas Wald (The Lancet, February 3rd). The two step approach - whereby women are first screened on the basis of age and then offered a serum screening test - should be avoided, say Dr Wald and his colleagues. It denies young women an inexpensive test and it is inefficient, they say.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT087396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel